
Tolrobest 2mg Tablet ER
Marketer
Leeford Healthcare Ltd
Salt Composition
Tolterodine (2mg)
Overview Tolrobest 2mg Tablet ER
For managing overactive bladder symptoms, Tolrobest 2mg Extended-Release tablets offer relief from frequent urination, urgency, and incontinence. Adhere strictly to your doctor's prescribed dosage and regimen. This medication can be taken with or without food, but maintain consistent timing. Always swallow the tablet whole; do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may worsen symptoms. Complete the full course for optimal therapeutic benefit. Potential side effects include dry mouth, constipation, diarrhea, urinary retention, and headache. Increased water intake may mitigate some side effects. Drowsiness, dizziness, or blurred vision are possible; avoid driving or tasks requiring alertness until these effects are known. Alcohol should be avoided due to potential side effect exacerbation. Report any persistent or bothersome side effects promptly. Prior to treatment, disclose all current medications and pre-existing conditions, including pregnancy or breastfeeding status. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their physician.
Uses of Tolrobest 2mg Tablet ER
Managing overactive bladder (OAB) signs and symptoms
Major Benefits of Tolrobest 2mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the 2mg Tolrobest Extended-Release tablet whole; do not chew, crush, or divide it. While you can take it with or without food, consistency is key – maintain a regular daily schedule.
Common Side effects of Tolrobest 2mg Tablet ER:
- Dryness in mouth
- Constipation
- Headache
- Dizziness
- Sleepiness
- Blurred vision
- Diarrhea
How to use Tolrobest 2mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2mg Tolrobest Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key—choose a regular time each day.
How Tolrobest 2mg Tablet ER works:
Tolrobest 2mg Extended-Release Tablets are classified as an antimuscarinic agent. Their mechanism of action involves relaxing bladder musculature, thus reducing urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tolrobest 2mg Extended-Release tablets and alcohol can lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tolrobest 2mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tolrobest 2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Prolonged Tolrobest 2mg tablet ER use may decrease breast milk supply.
DrivingUNSAFE
Extended-release Tolrobest 2mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Tolrobest 2mg Extended-Release tablets to individuals with impaired renal function. Dosage modification of Tolrobest 2mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Tolrobest 2mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tolrobest 2mg Tablet ER :
Should you forget a Tolrobest 2mg Extended-Release Tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Tolrobest 2mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
